Joe Fredette
Joe Fredette
Joe Fredette is a senior business development manager with the Biopharmaceuticals team at Waters. He is focused on understanding the analytical needs and challenges of our biopharmaceutical customers, and on applying that knowledge toward the development and promotion of LC-MS solutions that improve performance, solve analytical challenges, and fuel greater productivity.

Posts by author

Enhancing Analytical Productivity by Breaking Down Silos (Part 2)

By October 30, 2018

For biopharmaceutical organizations working with contract labs, it’s important to consider how data and methods will be transferred and how generated data will be managed so that it meets data integrity and compliance requirements.

Categories: Pharmaceutical
Tags: , , , , , , ,

Enhancing Analytical Productivity by Breaking Down Silos (Part 1)

By July 20, 2018

Analytical methods transfer. Data integrity. A changing and more stringent regulatory landscape. All this, and more, impacts productivity in upstream and downstream biopharmaceutical processes. How is Waters looking to help address development challenges for biologics and biosimilars?

Categories: Pharmaceutical
Tags: , , , , , ,

Oligo-mania! Interest in Oligonucleotides Continues to Rise

By July 7, 2017

From oligonucleotides and peptides to messenger RNA and CRISPR, ’tides are enjoying their time in the sun A year ago we wrote how oligonucleotide therapeutic development, which had seen a huge wave of investment in… Read more >

Categories: Pharmaceutical
Tags: , , , ,

Oligonucleotide Therapeutics on the Rise… Again

By July 7, 2016

Oligonucleotide drug development has seen its share of ups and downs over the past 20 years – but why? The promise of antisense oligonucleotides (ASOs) and later small interfering oligonucleotides (siRNAs) as therapeutics that can… Read more >

Categories: Pharmaceutical
Tags: ,